Identification and functional analysis of epigenetically silenced microRNAs in colorectal cancer cells

Hongli Yan1, Ae-Jin Choi, Byron H Lee

  • 1Genomic Medicine Institute, Cleveland Clinic Foundation, Cleveland, Ohio, United States of America.

Plos One
|June 24, 2011
PubMed

Insights

Epigenetic changes, specifically DNA methylation, influence microRNA (miRNA) expression in cancer. This study identifies novel DNA methylation-regulated miRNAs in colorectal cancer, revealing their functional role in inhibiting cancer cell growth and migration.

Area of Science:

  • Epigenetics
  • Cancer Biology
  • Molecular Oncology

Background:

  • Abnormal microRNA (miRNA) expression is implicated in cancer development.
  • Epigenetic alterations, particularly DNA methylation, are known to cause miRNA dysregulation.
  • The full extent of DNA methylation-mediated miRNA regulation in cancer remains largely unexplored.

Purpose of the Study:

  • To systematically identify novel microRNAs regulated by DNA methylation in colorectal cancer.
  • To investigate the functional significance of these epigenetically regulated miRNAs in cancer progression.
  • To establish a robust strategy for discovering DNA methylation-regulated miRNAs.

Main Methods:

  • Combined MBD-isolated Genome Sequencing (MiGS) for genome-wide DNA methylation profiling.
  • Microarray analysis to assess miRNA expression levels in colorectal cancer cell lines.
  • 5-aza-2'-deoxycytidine treatment to validate DNA methylation-regulated miRNAs.

Main Results:

  • Identified 64 methylated miRNAs in HCT116 colorectal cancer cells.
  • Discovered 8 novel miRNAs epigenetically silenced by DNA methylation.
  • Demonstrated that ectopic expression of these miRNAs inhibits cancer cell growth and migration.

Conclusions:

  • DNA methylation is a prevalent mechanism regulating miRNA expression in colorectal cancer.
  • Novel miRNAs are identified as targets of epigenetic silencing, impacting cancer cell phenotypes.
  • The study provides a systematic approach to uncover DNA methylation-driven miRNA dysregulation in cancer.